Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04726332
Title Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Exelixis Clinical Site #4 Atlanta Georgia 30322 United States Details
Exelixis Clinical Site #3 Boston Massachusetts 02215 United States Details
Exelixis Clinical Site #2 Dallas Texas 75230 United States Details
Exelixis Clinical Site #5 Houston Texas 77030 United States Details
Exelixis Clinical Site #1 San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field